Medical Pharmacology: Cancer Chemotherapy Drug Practice Questions
	Choose the correct answer for each question.
 
 
  
Mechanism of cellular resistance to polyfunctional alkylating drugs:
-   decreased DNA repair capability
 -   reduced production of glutathione
 -   increased permeability to the drug
 -   none of the above
 
 
Does not have direct vesicant effects:
-   mechlorethamine (Mustargen)
 -   carmustine (BNCU,BiCNU)
 -   cyclophosphamide (Cytoxan)
 -   A & B
 
 
Polyfunctional alkylating agent used specifically for chronic myeloid leukemia:
-   cyclophosphamide (Cytoxan)
 -   busulfan (Myleran)
 -   thiopeta (Thioplex)
 -   dacarbazine (DTIC)
 
 
Major toxicity of alkylating drugs:
-   alopecia
 -   myelosuppression
 -   renal damage
 -   hepatic failure
 
 
Most useful alkylating drug currently available:
-   melphalan (Alkeran)
 -   cyclophosphamide (Cytoxan)
 -   lomustine (CCNU,CeeNU)
 -   thiopeta (Thioplex)
 
 
Most common route of administration for melphalan (Alkeran):
-   oral
 -   iv
 
 
Most common route of administration for cyclophosphamide (Cytoxan):
-   iv
 -   oral
 
 
Nitrosourea with minimal bone-marrow suppression and effective in treating pancreatic, islet cell carcinoma.
-   lomustine (CCNU,CeeNU)
 -   carmustine (BNCU,BiCNU)
 -   streptozocin (Zanosar)
 -   procarbazine (Matulane)
 
 
Used in combination with vinblastine and bleomycin: a major advance in treating nonseminomatous testicular cancer:
-   altretamine (Hexalen)
 -   cisplatin (Platinol)
 -   procarbazine (Matulane)
 -   methotrexate
 
 
Little effect on the bone marrow: can cause significant renal dysfunction and sometimes acoustic nerve dysfunction.
-   methotrexate
 -   cisplatin (Platinol)
 -   lomustine (CCNU,CeeNU)
 -   A & C
 
 
Anticancer drug that is also used to treat psoriasis and rheumatoid arthritis:
-   mercaptomurine (6-MP)
 -   methotrexate
 -   procarbazine (Matulane)
 -   allopurinol (Zyloprim, Purinol)
 
 
Combination of allopurinol with this anticancer drug can cause an increase in toxicity:
-   6-thioguanine
 -   flurouracil (5-FU)
 -   6-mercaptopurine
 -   azatadine (Optimine)
 
 
Recommended for treating hairy cell leukemia
-   methotrexate
 -   cladribine (Leustatin)
 -   vinblastine (Velban) 
 -   cytarabine (ara-C)
 
 
	
	
	
	
	
	
		
			| 
			 
			If  you wish to return to the Table of Contents 
			in ENGLISH, press the RETURN button above.  | 
		
	
			 
 
	
		
			| 
			 
			Otherwise, if the text is NOT displayed in 
			English and you are ready to leave this page,
			Press here
			to return to the Table of Contents     
			
			   |